What is GeneTex?
GeneTex is a prominent producer and supplier of critical reagents for biomedical research, including antibodies, proteins, and lysates. The company caters to academic institutions, pharmaceutical firms, and research laboratories, providing validated tools essential for scientific discovery. Their commitment to rigorous antibody validation and their offerings of bulk and custom services highlight their dedication to supporting the research community. The company's focus on quality and reliability positions it as a key player in the life sciences supply chain.
How much funding has GeneTex raised?
GeneTex has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in GeneTex
PPP
Public-Private Partnership
What's next for GeneTex?
With substantial late-stage financing, GeneTex is poised for accelerated growth and expansion. This strategic investment will likely fuel advancements in product development, enhance manufacturing capabilities, and broaden market reach. The company is expected to leverage this capital to solidify its competitive advantage, potentially exploring new research areas or strengthening its existing portfolio of high-performance research reagents. GeneTex's continued focus on quality assurance and customer support will be pivotal in navigating its next phase of development.
See full GeneTex company page
